Quantcast
Last updated on April 21, 2014 at 8:49 EDT

Latest Rifampicin Stories

2013-09-09 08:42:31

Results of a new study suggest that three new diagnostic tests could each be used to successfully diagnose drug resistance in tuberculosis (TB) patients in a quarter of the time taken by the current method. The research, presented today (8 September 2013) at the European Respiratory Society's Annual Congress in Barcelona, has provided evidence that each test could be used as an effective alternative to standard testing, increasing the possibilities open to clinicians. Drug...

2013-08-28 08:25:49

Revolutionary Tuberculosis Test Brings Accurate, Faster Results to Broader U.S. Market SUNNYVALE, Calif., Aug. 28, 2013 /PRNewswire/ -- Cepheid (NASDAQ: CPHD) today announced the U.S. Food & Drug Administration (FDA) has categorized Cepheid's Xpert(®) MTB/RIF test as 'Moderate Complexity' under the Clinical Laboratory Improvement Amendments (CLIA). Xpert MTB/RIF is designed for the rapid molecular detection of Mycobacterium tuberculosis complex (MTB-complex) DNA and, in specimens where...

DNA Detection Breakthrough Could Lead To Improved Tuberculosis Treatments
2013-07-29 13:22:02

Brett Smith for redOrbit.com - Your Universe Online Minor mutations in DNA code can make for major malfunctions, and a breakthrough technique has allowed scientists to spot genetic changes with greater precision than ever. According to a new report in the journal Nature Chemistry, the new method can look at a specific DNA sequence and pull out a single mutation. "We've really improved on previous approaches because our solution doesn't require any complicated reactions or added...

2013-07-25 20:21:17

Revolutionary Tuberculosis Test Brings Accurate, Faster Results to U.S. Market SUNNYVALE, Calif., July 25, 2013 /PRNewswire/ --Cepheid (Nasdaq: CPHD) today announced it has received market authorization from the U.S. Food & Drug Administration (FDA) for its Xpert(®) MTB/RIF test. The review decision was based on the de novo 510(k) review process, which allows novel products without predicates to be down-classified and brought to market. Xpert MTB/RIF is designed for the rapid...

2013-06-17 08:29:45

RARITAN, N.J., June 17, 2013 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen) today welcomes the World Health Organization (WHO) interim policy guidance on the use of bedaquiline (trade name SIRTURO(TM) in the U.S.) in the treatment of pulmonary multi-drug resistant tuberculosis (MDR-TB) as part of combination therapy in adults. The guidance culminates a rigorous review process by internal and external TB experts convened by the WHO and drew upon available Phase 2 safety and...

2013-05-21 12:28:40

NEW YORK, May 21, 2013 /PRNewswire-USNewswire/ -- In a striking, unexpected discovery, researchers at Albert Einstein College of Medicine of Yeshiva University have determined that vitamin C kills drug-resistant tuberculosis (TB) bacteria in laboratory culture. The finding suggests that vitamin C added to existing TB drugs could shorten TB therapy, and it highlights a new area for drug design. The study was published today in the online journal Nature Communications. (Logo:...

2013-01-31 14:59:28

A diagnostic test for tuberculosis (TB) can accurately and quickly detect both TB and drug-resistant strains, according to a new study. The authors of a new systematic review assessing the diagnostic accuracy of the Xpert® MTB/RIF test published in The Cochrane Library say their study can provide timely advice for clinicians and policymakers in countries where TB is a major public health problem. Millions of people develop TB every year. Around 13% of cases occur in people living with...

2013-01-28 13:52:49

Vanderbilt biochemists have discovered that the process bacteria undergo when they become drug resistant can act as a powerful tool for drug discovery. Their findings — reported this week in the Online Early Edition of the Proceedings of the National Academy of Sciences — should give a major boost to natural products drug discovery — the process of finding new drugs from compounds isolated from living organisms — by substantially increasing the number of novel...

2012-09-20 02:28:47

PARIS and NEW YORK, Sept. 20, 2012 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) and the Global Alliance for TB Drug Development (TB Alliance) announced today a new research collaboration agreement to accelerate the discovery and development of novel compounds against tuberculosis (TB), a deadly infectious disease that resulted in almost 1.5 million deaths worldwide(1) in 2010. (Logo: http://photos.prnewswire.com/prnh/20110616/NY20158LOGO ) Under the agreement, Sanofi and...

2011-07-27 05:59:27

(Ivanhoe Newswire) -- Two research studies suggest that a new automated DNA test for tuberculosis (Xpert MTB/RIF), which can detect TB within 2 hours and has been endorsed by the World Health Organization, can significantly increase TB detection rate compared to other tests, particularly in HIV positive patients who have a high risk of being infected with TB, including multidrug resistant TB. In the first study, led by Stephen Lawn from the Desmond Tutu HIV Centre at the University of Cape...


Latest Rifampicin Reference Libraries

72_0ab04c9452ae9b3c6ae51f6deb1bcc35
2011-04-25 16:19:14

Mycobacterium tuberculosis (MTB) is a pathogenic bacterial species in the genus Mycobacterium and the causative agent of most cases of tuberculosis. Robert Koch first discovered it in 1882 and that it had an unusual, waxy coating on the cell surface which makes them impossible to Gram stain. M. tuberculosis is highly aerobic and requires high levels of oxygen. It generally infects the respiratory system of mammals. Tuberculin skin test, acid-fast stain, and chest radiographs are the most...

More Articles (1 articles) »